Clinical Trial Update: Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating safety and efficacy of DCVAC/LuCa immunotherapy in patients with metastatic non-small cell lung cancer (Stage IV).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DCVAC/LuCa (DCVAC/LuCa)

Snippet

Sponsor: SOTIO a.s. | Conditions: Stage IV Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED